Bausch Health Companies Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Bausch Health Companies Inc.
Inventiva’s pan-PPAR agonist and Terns’ combination strategy are targeting the NASH treatment paradigm after expected approval of Madrigal’s resmetirom. Viking is hoping to prove a better THRβ drug profile than Madrigal.
Lumify sales up 47% to reported $44m in Q3 as brand and firm’s vision health vitamins Ocuvite and PreserVision remain key drivers for its vision care segment, which also includes contact lenses and solutions.
Private Company Edition: Quarter-over-quarter increases in venture capital have been bolstered by fewer but larger rounds, like the recent $245m series A for Aiolos. Also, OrbiMed raised $4.3bn across three new VC funds, Rampart completed an $85m series A and Atom Bioscience raised an $83m series D.
Two years after its first FDA review, UCB’s next blockbuster Bimzelx finally crossed the finish line. Supplemental filings for more indications will soon follow as the company forecasts €4bn in peak sales.
- Medical Devices
- Generic Drugs
- OTC, Consumer
- Implantable Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
- AB Sanitas
- Afexa Life Sciences Inc.
- Amoun Pharmaceutical
- Aton Pharma, Inc.
- Bausch Health Ireland Limited
- Bausch + Lomb Holding International
- Biovail Corporation
- Callisto Pharmaceuticals, Inc. Dendreon Corporation
- Dermik Laboratories, Inc.
- Dow Pharmaceutical Sciences, Inc.
- Eyetech Inc.
- Graceway Pharmaceuticals, LLC
- ICN Pharmaceuticals, Inc.
- iNova Diagnostics, Inc.
- Instituto Terapeutico Delta Ltda
- Medicis Aesthetics Holdings Inc
- Medicis Pharmaceutical Corporation
- Mercury (Cayman) Holdings
- OraPharma, Inc.
- Ortho Dermatologics
- Prestwick Pharmaceuticals, Inc.
- PharmaSwiss S.A.
- Pedinol Pharmacal, Inc.
- Salix Pharmaceuticals Ltd. (InKine Pharmaceutical
- Oceana Therapeutics, LLC
- Q-Med Scandinavia, Inc.
- Santarus, Inc.)
- Sanitas AB
- Solta Medical, Inc.
- SPI Pharmaceuticals Inc
- Synergetics USA, Inc.
- Synergy Pharmaceuticals Inc.(SGYP)
- Technolas Perfect Vision GmbH (TPV)
- Ucyclyd Pharma, Inc.
- Unilens Vision, Inc.
- Viratek Pharma Inc
- Valeant Pharmaceuticals International, Inc.
- Xcel Pharmaceuticals, Inc.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.